Univ.-Prof. Dipl.-Ing. Dr. Manfred Ogris
Manfred Ogris
41 - 60 out of 113

Gruenwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R et al. Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene. The Journal of Nuclear Medicine. 2013 Aug;54(8):1450-1457. doi: 10.2967/jnumed.112.115493

Haase R, Magnusson T, Su B, Kopp F, Wagner E, Lipps H et al. Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC Biotechnology. 2013 Jun 4;13:49. doi: 10.1186/1472-6750-13-49

Vetter A, Virdi KS, Espenlaub S, Roedl W, Wagner E, Kreppel F et al. Non-Covalent Coating of Adenoviral Vectors with PAMAM Dendrimer Conjugates Allows for CAR Independent Virus Uptake and Targeting to the EGF Receptor. Molecular Therapy. 2013 Jun;21(S1):S54. doi: https://doi.org/10.1016/S1525-0016(16)34469-0

Vetter A, Virdi KS, Espenlaub S, Roedl W, Wagner E, Holm PS et al. Adenoviral Vectors Coated with PAMAM Dendrimer Conjugates Allow CAR Independent Virus Uptake and Targeting to the EGF Receptor. Molecular Pharmaceutics. 2013 Feb;10(2):606-618. doi: 10.1021/mp300366f

Su B, Cengizeroglu A, Farkasova K, Viola JR, Anton M, Ellwart JW et al. Systemic TNF alpha Gene Therapy Synergizes With Liposomal Doxorubicine in the Treatment of Metastatic Cancer. Molecular Therapy. 2013 Feb;21(2):300-308. doi: 10.1038/mt.2012.229

Terziyska N, Alves CC, Groiss V, Schneider K, Farkasova K, Ogris M et al. In Vivo Imaging Enables High Resolution Preclinical Trials on Patients' Leukemia Cells Growing in Mice. PLoS ONE. 2012 Dec 31;7(12):52798. doi: 10.1371/journal.pone.0052798


Gruenwald G, Vetter A, Klutz K, Willhauck M, Senekowitsch-Schmidtke R, Schwaiger M et al. EGFR-specific retargeting of a dendrimer-coated adenovirus carrying the sodium iodide symporter (NIS) for systemic radiovirotherapy of liver cancer. Human Gene Therapy. 2012 Oct;23(10):A93-A94.

Viola J, Grayeski P, Graf S, Kopp F, Wagner E, Besch R et al. Nonviral gene delivery to melanoma combining selective cellular uptake and tumour-specific transcription. Human Gene Therapy. 2012 Oct;23(10):A146-A146.



Abourbeh G, Shir A, Mishani E, Ogris M, Roedl W, Wagner E et al. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors. IUBMB Life. 2012 Apr;64(4):324-330. doi: 10.1002/iub.1002

Buyens K, De Smedt SC, Braeckmans K, Demeester J, Peeters L, van Grunsven LA et al. Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design. Journal of Controlled Release. 2012 Mar 28;158(3):362-370. doi: 10.1016/j.jconrel.2011.10.009

Klutz K, Willhauck MJ, Dohmen C, Wunderlich N, Knoop K, Zach C et al. Image-Guided Tumor-Selective Radioiodine Therapy of Liver Cancer After Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Human Gene Therapy. 2011 Dec;22(12):1563-1574. doi: 10.1089/hum.2011.041


Shir A, Levitzki A, Wagner E, Klein S, Ogris M. Nucleic Acid-Based Therapeutics for Glioblastoma. Anti-Cancer Agents in Medicinal Chemistry. 2011 Oct;11(8):693-699.


Nie Y, Schaffert D, Roedl W, Ogris M, Wagner E, Guenther M. Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy. Journal of Controlled Release. 2011 May 30;152(1):127-134. doi: 10.1016/j.jconrel.2011.02.028

Dussmann P, Pagel JI, Vogel S, Magnusson T, Zimmermann R, Wagner E et al. Live in vivo imaging of Egr-1 promoter activity during neonatal development, liver regeneration and wound healing. BMC Developmental Biology. 2011 May 20;11:28. doi: 10.1186/1471-213X-11-28

41 - 60 out of 113

Water-soluble NHC stabilized Gold Nanoparticles

Michael Reithofer (Speaker), Jia Min Chin (Contributor), Adam J. Young (Speaker), Haider Sami (Contributor), Constantin Eisen (Contributor), Guilherme Rubio (Contributor), Nathalie Tepe (Contributor), Thilo Hofmann (Contributor), Manfred Ogris (Contributor) & Bernhard Keppler (Contributor)

11 Aug 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Compact

Ogris, M. & Urban, E.

1/11/1231/10/17

Project: Research funding


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D450

T: +43-1-4277-55551

m.ogris@univie.ac.at